Stefano V. Gulla

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating disorders associated with excess or unwanted ki...
- Patent number 12,139,541
- Issue date Nov 12, 2024
- Abcuro, Inc.
- Stefano Vincenzo Gulla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant ROBO2 proteins, compositions, methods and uses thereof
- Patent number 11,970,524
- Issue date Apr 30, 2024
- Pfizer Inc.
- Stephen Berasi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Interferon beta antibodies and uses thereof
- Patent number 11,858,986
- Issue date Jan 2, 2024
- Pfizer Inc.
- Stefano V. Gulla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ROBO2 antibodies, compositions, methods and uses thereof
- Patent number 11,365,253
- Issue date Jun 21, 2022
- Pfizer Inc.
- Stephen Berasi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
KLRG1 antagonist signaling therapy
- Patent number 11,339,222
- Issue date May 24, 2022
- The Brigham & Women's Hospital, Inc.
- Steven Greenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Killer cell lectin-like receptor subfamily G member 1 (KLRG1) deple...
- Patent number 11,180,561
- Issue date Nov 23, 2021
- Abcuro, Inc.
- Stefano Vincenzo Gulla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Recombinant ROBO2 proteins, compositions, methods and uses thereof
- Patent number 10,906,955
- Issue date Feb 2, 2021
- Pfizer Inc.
- Stephen Berasi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interferon beta antibodies and uses thereof
- Patent number 10,829,553
- Issue date Nov 10, 2020
- Pfizer Inc.
- Stefano V. Gulla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CD21 ANTIBODIES AND USES THEREOF
- Publication number 20240376225
- Publication date Nov 14, 2024
- The Children's Medical Center Corporation
- Hulian GAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-KLRG1 ANTIBODIES
- Publication number 20240174754
- Publication date May 30, 2024
- Abcuro, Inc.
- Stefano V. GULLA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON BETA ANTIBODIES AND USES THEREOF
- Publication number 20240174742
- Publication date May 30, 2024
- Pfizer Inc.
- Stefano V. Gulla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLE...
- Publication number 20220089747
- Publication date Mar 24, 2022
- Abcuro, Inc.
- Stefano Vincenzo Gulla
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-KLRG1 ANTIBODIES
- Publication number 20210347899
- Publication date Nov 11, 2021
- Abcuro, Inc.
- Stefano V GULLA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RECOMBINANT ROBO2 PROTEINS, COMPOSITIONS, METHODS AND USES THEREOF
- Publication number 20210214414
- Publication date Jul 15, 2021
- Pfizer Inc.
- Stephen Berasi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON BETA ANTIBODIES AND USES THEREOF
- Publication number 20210163588
- Publication date Jun 3, 2021
- Pfizer Inc.
- Stefano V. Gulla
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLE...
- Publication number 20200325233
- Publication date Oct 15, 2020
- Abcuro, Inc.
- Stefano Vincenzo Gulla
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-ROBO2 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF
- Publication number 20200157212
- Publication date May 21, 2020
- Pfizer Inc.
- Stephen Berasi
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
KLRG1 SIGNALING THERAPY
- Publication number 20190292264
- Publication date Sep 26, 2019
- THE BRIGHAM AND WOMEN'S HOSPITAL
- Steven Greenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KLRG1 DEPLETION THERAPY
- Publication number 20190194333
- Publication date Jun 27, 2019
- The Brigham & Women's Hospital, Inc.
- Steven Greenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KLRG1 SIGNALING THERAPY
- Publication number 20190085083
- Publication date Mar 21, 2019
- THE BRIGHAM AND WOMEN'S HOSPITAL
- Steven Greenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RECOMBINANT ROBO2 PROTEINS, COMPOSITIONS, METHODS AND USES THEREOF
- Publication number 20180346542
- Publication date Dec 6, 2018
- Pfizer Inc.
- Stephen Berasi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON BETA ANTIBODIES AND USES THEREOF
- Publication number 20170313769
- Publication date Nov 2, 2017
- Pfizer Inc.
- Stefano V. Gulla
- C07 - ORGANIC CHEMISTRY

Stefano V. Gulla

Person

Patents Grantslast 30 patents

Methods of treating disorders associated with excess or unwanted ki...

Recombinant ROBO2 proteins, compositions, methods and uses thereof

Interferon beta antibodies and uses thereof

Anti-ROBO2 antibodies, compositions, methods and uses thereof

KLRG1 antagonist signaling therapy

Killer cell lectin-like receptor subfamily G member 1 (KLRG1) deple...

Recombinant ROBO2 proteins, compositions, methods and uses thereof

Interferon beta antibodies and uses thereof

Patents Applicationslast 30 patents

CD21 ANTIBODIES AND USES THEREOF

ANTI-KLRG1 ANTIBODIES

INTERFERON BETA ANTIBODIES AND USES THEREOF

KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLE...

ANTI-KLRG1 ANTIBODIES

RECOMBINANT ROBO2 PROTEINS, COMPOSITIONS, METHODS AND USES THEREOF

INTERFERON BETA ANTIBODIES AND USES THEREOF

KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) DEPLE...

ANTI-ROBO2 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF

KLRG1 SIGNALING THERAPY

KLRG1 DEPLETION THERAPY

KLRG1 SIGNALING THERAPY

RECOMBINANT ROBO2 PROTEINS, COMPOSITIONS, METHODS AND USES THEREOF

INTERFERON BETA ANTIBODIES AND USES THEREOF